E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 8/17/2016 in the Prospect News PIPE Daily.

Zomedica Pharmaceuticals eyes C$15 million private placement of stock

Company sells 10 million shares at C$1.50 through non-brokered deal

By Devika Patel

Knoxville, Tenn., Aug. 17 – Zomedica Pharmaceuticals Corp. said it plans a C$15 million non-brokered private placement of stock.

The company will sell 10 million common shares at C$1.50 per share. The price per share is a 3.45% premium to the Aug. 16 closing share price of C$1.45.

The company will use the proceeds for development of its therapeutic pipeline, acquisitions, furthering its intellectual property and associated protections, capital markets activities and expenditures and general working capital purposes.

The pharmaceutical company is based in Ann Arbor, Mich.

Issuer:Zomedica Pharmaceuticals Corp.
Issue:Common shares
Amount:C$15 million
Shares:10 million
Price:C$1.50
Warrants:No
Agent:Non-brokered
Pricing date:Aug. 17
Stock symbol:TSX Venture: ZOM
Stock price:C$1.45 at close Aug. 16
Market capitalization:C$44.26 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.